Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

alendronate

APO-ALENDRONATE

alendronate (APO-ALENDRONATE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 11
Pipeline programs 5
News articles 0
Drug details — alendronate
Class
—
Route
—
Patents
11
Programs
5
Data quality
0.81
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

alendronate (APO-ALENDRONATE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

Key facts

INN alendronate
Brand APO-ALENDRONATE
Originator Alphapharm Pty Ltd

Approval history

Authority Status Date
TGA approved —

Pipeline programs

Browse pipeline Sponsor programs
  1. SAVE PAIN 2025 Phase 3 · Théa Pharma Ireland · PARKINSON’S DISEASE WITH MOTOR FLUCTUATIONS
  2. Ademetionine 1,4-Butanedisulfonate Phase 2 · Chinese Academy of · Obstructive Hypertrophic Cardiomyopathy (oHCM)
  3. Alendronate Sodium Tablets 70mg Phase 1 · Teva Pharma · Healthy
  4. Alendronate Approved · Hospital Authority · Non-Traumatic Osteonecrosis
  5. Alendronate Approved · Chinese Academy of · Osteogenesis Imperfecta

Related patents

Browse patents Alphapharm Pty Ltd patent hub

  1. CN 117186084

    Pranlerivir sulfonate, and pharmaceutical preparation, preparation method and application thereof in treatment of herpes virus

    Expires Thu Dec 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10251955

    Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins

    Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10000582

    Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9700628

    Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8450390

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8247598

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8222282

    Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8097695

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7598338

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7312301

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 6476006

    Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates

    Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is alendronate?

alendronate (APO-ALENDRONATE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

What is the brand name for alendronate?

APO-ALENDRONATE is a marketed brand name for alendronate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.